{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:34:49Z","timestamp":1795026889994,"version":"4.10.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA038608"],"award-info":[{"award-number":["R01 DA038608"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the United States, the high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial\/ethnic minorities calls for understanding factors that contribute to making progress in treatment. Whereas counseling and medication for OUD (MOUD, e.g. methadone, buprenorphine, naltrexone) is considered the gold standard of care in substance use disorder (SUD) treatment, many individuals with OUD receive either counseling or methadone-only services. This study evaluates gender disparities in treatment plan progress in methadone- compared to counseling-based programs in one of the largest SUD treatment systems in the United States.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Multi-year and multi-level (treatment program and client-level) data were analyzed using the Integrated Substance Abuse Treatment to Eliminate Disparities (iSATed) dataset collected in Los Angeles County, California. The sample consisted of 4 waves: 2011 (66 SUD programs, 1035 clients), 2013 (77 SUD programs, 3686 clients), 2015 (75 SUD programs, 4626 clients), and 2017 (69 SUD programs, 4106 clients). We conducted two multi-level negative binomial regressions, one per each outcome (1) making progress towards completing treatment plan, and (2) completing treatment plan. We included outpatient clients discharged on each of the years of the study (over 95% of all clients) and accounted for demographics, wave, homelessness and prior treatment episodes, as well as clients clustered within programs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We detected gender differences in two treatment outcomes (progress and completion) considering two outpatient program service types (MOUD-methadone vs. counseling). Clients who received methadone vs. counseling had lower odds of completing their treatment plan (OR\u2009=\u20090.366; 95% CI\u2009=\u20090.163, 0.821). Female clients receiving methadone had lower odds of both making progress (OR\u2009=\u20090.668; 95% CI\u2009=\u20090.481, 0.929) and completing their treatment plan (OR\u2009=\u20090.666; 95% CI\u2009=\u20090.485, 0.916) compared to male clients and receiving counseling. Latina clients had lower odds of completing their treatment plan (OR\u2009=\u20090.617; 95% CI\u2009=\u20090.408, 0.934) compared with non-Latina clients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clients receiving methadone, the most common and highly effective MOUD in reducing opioid use, were less likely to make progress towards or complete their treatment plan than those receiving counseling. Women, and in particular those identified as Latinas, were least likely to benefit from methadone-based programs. These findings have implications for health policy and program design that consider the need for comprehensive and culturally responsive services in methadone-based programs to improve outpatient treatment outcomes among women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13011-021-00389-4","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:04:21Z","timestamp":1624435461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gender disparities in opioid treatment progress in methadone versus counseling"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3086-5710","authenticated-orcid":false,"given":"Erick","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenie","family":"Khachikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"389_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.06.006","volume":"190","author":"GJ Stahler","year":"2018","unstructured":"Stahler GJ, Mennis J. Treatment outcome disparities for opioid users: are there racial and ethnic differences in treatment completion across large US metropolitan areas? Drug Alcohol Depend. 2018;190:170\u20138.","journal-title":"Drug Alcohol Depend."},{"key":"389_CR2","first-page":"47","volume":"7","author":"D Mahon","year":"2020","unstructured":"Mahon D. Improving retention in opioid treatment. J Addict Addictv Disord. 2020;7:47.","journal-title":"J Addict Addictv Disord."},{"key":"389_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4172\/2155-6105.1000360","volume":"9","author":"BW Roberts","year":"2018","unstructured":"Roberts BW, Perches L, Sagiraju HKR, Cech I, Herbold J. \u201cReal World\u201d factors influencing dropout from opiate treatment with methadone and buprenorphine. J Addict Res Ther. 2018;9:360. https:\/\/doi.org\/10.4172\/2155-6105.1000360.","journal-title":"J Addict Res Ther."},{"key":"389_CR4","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. Medications for opioid use disorder save lives. Washington, DC: The National Academies Press; 2019. https:\/\/doi.org\/10.17226\/25310.","DOI":"10.17226\/25310"},{"key":"389_CR5","unstructured":"Office on Women\u2019s Health. White paper: opioid use, misuse, and overdose in women; 2016. https:\/\/www.womenshealth.gov\/files\/documents\/white-paper-opioid-508.pdf."},{"issue":"1","key":"389_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1377\/hlthaff.2011.0983","volume":"32","author":"B Saloner","year":"2013","unstructured":"Saloner B, L\u00ea Cook B. Blacks and hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Aff (Project Hope). 2013;32(1):135\u201345. https:\/\/doi.org\/10.1377\/hlthaff.2011.0983.","journal-title":"Health Aff (Project Hope)."},{"key":"389_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.drugalcdep.2018.05.033","volume":"192","author":"JR Gaither","year":"2018","unstructured":"Gaither JR, Gordon K, Crystal S, Edelman EJ, Kerns RD, Justice AC, et al. Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. Drug Alcohol Depend. 2018;192:371\u20136.","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"389_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/00952990.2011.591016","volume":"37","author":"D Cao","year":"2011","unstructured":"Cao D, Marsh JC, Shin H-C, Andrews C. Improving health and social outcomes with targeted services in comprehensive substance abuse treatment. Am J Drug Alcohol Ab. 2011;37(4):250\u20138. https:\/\/doi.org\/10.3109\/00952990.2011.591016.","journal-title":"Am J Drug Alcohol Ab."},{"issue":"5","key":"389_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jsat.2013.12.008","volume":"46","author":"EG Guerrero","year":"2015","unstructured":"Guerrero EG, Marsh JC, Cao DC, Shin HC, Andrews C. Gender disparities in utilization and outcome of comprehensive substance abuse treatment among racial\/ethnic groups. J Subst Abus Treat. 2015;46(5):584\u201391.","journal-title":"J Subst Abus Treat."},{"key":"389_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.evalprogplan.2008.09.003","volume":"32","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Cao D, Guerrero E, Shin H. Need-service matching in substance abuse treatment: racial\/ethnic differences. Eval Program Plann. 2009;32:43\u20135.","journal-title":"Eval Program Plann."},{"issue":"4","key":"389_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1037\/adb0000090","volume":"29","author":"SL Proctor","year":"2015","unstructured":"Proctor SL, Copeland AL, Kopak AM, Hoffmann NG, Herschman PL, Polukhina N. Predictors of patient retention in methadone maintenance treatment. Psychol Addict Behav. 2015;29(4):906\u201317.","journal-title":"Psychol Addict Behav."},{"issue":"2","key":"389_CR12","first-page":"37","volume":"64","author":"EC Ailes","year":"2015","unstructured":"Ailes EC, Dawson AL, Lind JN. Opioid prescription claims among women of reproductive age\u2014united states, 2008\u20132012. MMWR. 2015;64(2):37\u201341.","journal-title":"MMWR."},{"key":"389_CR13","unstructured":"Centers for Disease Control and Prevention (CDC). Annual surveillance report of drug-related risks and outcomes. Atlanta: CDC; 2017. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2017-cdc-drug-surveillance-report.pdf."},{"key":"389_CR14","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","volume":"36","author":"N Krawczyk","year":"2017","unstructured":"Krawczyk N, Picher CE, Feder KA, Saloner B. Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Aff. 2017;36:2046\u201353. https:\/\/doi.org\/10.1377\/hlthaff.2017.0890.","journal-title":"Health Aff."},{"key":"389_CR15","unstructured":"FORE. Opioid response efforts to improve access to opioid treatment; 2020. https:\/\/www.prnewswire.com\/news-releases\/foundation-for-opioid-response-efforts-fore-announces-10-1-million-in-grants-to-improve-access-to-opioid-treatment-301022292.html."},{"key":"389_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addbeh.2019.01.041","volume":"93","author":"J Mennis","year":"2019","unstructured":"Mennis J, Stahler GJ, Abou El Magd S, Baron DA. How long does it take to complete outpatient substance use disorder treatment? Disparities among Blacks, Hispanics, and Whites in the US. Addict Behav. 2019;93:158\u201365.","journal-title":"Addict Behav."},{"issue":"3","key":"389_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.drugalcdep.2013.03.015","volume":"132","author":"S Arndt","year":"2013","unstructured":"Arndt S, Acion L, White K. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug Alcohol Depend. 2013;132(3):547\u201354.","journal-title":"Drug Alcohol Depend."},{"issue":"6\u20137","key":"389_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.addbeh.2009.01.002","volume":"34","author":"CE Grella","year":"2009","unstructured":"Grella CE, Karno MP, Warda US, Niv N, Moore AA. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav. 2009;34(6\u20137):498\u2013504. https:\/\/doi.org\/10.1016\/j.addbeh.2009.01.002.","journal-title":"Addict Behav."},{"issue":"4","key":"389_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jsat.2004.08.004","volume":"27","author":"JC Marsh","year":"2004","unstructured":"Marsh JC, Cao D, D\u2019Aunno T. Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abus Treat. 2004;27(4):289\u2013300.","journal-title":"J Subst Abus Treat."},{"issue":"8","key":"389_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1046\/j.1360-0443.2000.958123710.x","volume":"95","author":"JC Marsh","year":"2000","unstructured":"Marsh JC, D\u2019Aunno TA, Smith BD. Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction. 2000;95(8):1237\u201347. https:\/\/doi.org\/10.1046\/j.1360-0443.2000.958123710.x.","journal-title":"Addiction."},{"issue":"1","key":"389_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2005.07.002","volume":"30","author":"A-P Sun","year":"2006","unstructured":"Sun A-P. Program factors related to women\u2019s substance abuse treatment retention and other outcomes: a review and critique. J Subst Abus Treat. 2006;30(1):1\u201320.","journal-title":"J Subst Abus Treat."},{"issue":"2","key":"389_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/002204260403400208","volume":"34","author":"YI Hser","year":"2004","unstructured":"Hser YI, Huang YC, Teruya C, Anglin MD. Gender differences in treatment outcomes over a three-year period: a PATH model analysis. J Drug Issues. 2004;34(2):419\u201339.","journal-title":"J Drug Issues."},{"key":"389_CR23","first-page":"20","volume":"108399","author":"JC Marsh","year":"2021","unstructured":"Marsh JC, Amaro H, Kong Y, Khachikian T, Guerrero E. Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities. J Subst Abus Treat. 2021 Apr;108399:20.","journal-title":"J Subst Abus Treat."},{"issue":"1","key":"389_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/16066350009004410","volume":"8","author":"M Maglione","year":"2000","unstructured":"Maglione M, Chao B, Anglin D. Residential treatment of methamphetamine users: correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994\u20131997. Addict Res. 2000;8(1):65\u201379.","journal-title":"Addict Res."},{"key":"389_CR25","doi-asserted-by":"crossref","unstructured":"Brady TM, Ashley OS, editors. Women in substance abuse treatment: results from the alcohol and drug services study (ADSS). DHHS Pub. No. SMA 04\u20133968, Analytic Series A\u201326. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2005.","DOI":"10.1037\/e441962005-001"},{"key":"389_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1360-0443.2004.00964.x","volume":"100","author":"DA Dawson","year":"2005","unstructured":"Dawson DA, Grant BF, Stinson FS, Chou PS, Huang B, Ruan WA. Recovery from DSM\u2013IV alcohol dependence: United States, 2001\u20132002. Addiction. 2005;100:281\u201392.","journal-title":"Addiction."},{"key":"389_CR27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.15288\/jsa.2003.64.862","volume":"64","author":"C Weisner","year":"2003","unstructured":"Weisner C, Delucchi K, Matzger H, Schmidt L. The role of community services and informal support on five-year drinking trajectories of alcohol dependent and problem drinkers. J Stud Alcohol. 2003;64:862\u201373.","journal-title":"J Stud Alcohol."},{"key":"389_CR28","doi-asserted-by":"publisher","first-page":"108028","DOI":"10.1016\/j.jsat.2020.108028","volume":"114","author":"MS Askari","year":"2020","unstructured":"Askari MS, Martins SS, Mauro PM. Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: differences in retention and completion among opioid-related discharges in 2016. J Subst Abus Treat. 2020;114:108028.","journal-title":"J Subst Abus Treat."},{"issue":"1","key":"389_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-597X-6-1","volume":"6","author":"TS Lee","year":"2011","unstructured":"Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, et al. Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Subst Ab Treat Prev Policy. 2011;6(1):1\u20137.","journal-title":"Subst Ab Treat Prev Policy."},{"issue":"2","key":"389_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jsat.2008.11.004","volume":"37","author":"KF Corsi","year":"2009","unstructured":"Corsi KF, Lehman WK, Booth RE. The effect of methadone maintenance on positive outcomes for opiate injection drug users. J Subst Abus Treat. 2009;37(2):120\u20136. https:\/\/doi.org\/10.1016\/j.jsat.2008.11.004.","journal-title":"J Subst Abus Treat."},{"issue":"1","key":"389_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00952990802342899","volume":"35","author":"YP Bao","year":"2009","unstructured":"Bao YP, Liu ZM, Epstein DH, Du C, Shi J, Lu L. A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am J Drug Alcohol Ab. 2009;35(1):28\u201333. https:\/\/doi.org\/10.1080\/00952990802342899.","journal-title":"Am J Drug Alcohol Ab."},{"key":"389_CR32","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):CD002209. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2.","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"2\u20133","key":"389_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","volume":"91","author":"TW Kinlock","year":"2007","unstructured":"Kinlock TW, Gordon MS, Schwartz RP, O\u2019Grady K, Fitzgerald TT, Wilson M. A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release. Drug Alcohol Depend. 2007;91(2\u20133):220\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.05.022.","journal-title":"Drug Alcohol Depend."},{"key":"389_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.drugalcdep.2019.02.007","volume":"197","author":"S Ling","year":"2019","unstructured":"Ling S, Mangaoil R, Cleverley K, Sproule B, Puts M. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions. Drug Alcohol Depend. 2019;197:168\u201382.","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"389_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/add.12333","volume":"109","author":"YI Hser","year":"2014","unstructured":"Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, et al. Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79\u201387.","journal-title":"Addiction."},{"issue":"8","key":"389_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/jama.2020.8969","volume":"324","author":"T Beetham","year":"2020","unstructured":"Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. Therapies offered at residential addiction treatment programs in the united states. JAMA. 2020;324(8):804\u20136. https:\/\/doi.org\/10.1001\/jama.2020.8969.","journal-title":"JAMA."},{"key":"389_CR37","unstructured":"Clemans-Cope L, Epstein M, Wissoker D. County-level estimates of opioid use disorder and treatment needs in California. The Urban Institute; 2018. https:\/\/www.urban.org\/sites\/default\/files\/2018\/03\/20\/alpine.pdf."},{"key":"389_CR38","unstructured":"Los Angeles County Department of Public Health, Substance Abuse Prevention and Control Prescription Drug Abuse in Los Angeles County. 2013. http:\/\/publichealth.lacounty.gov\/docs\/HealthNews\/PrescriptionDrug-12-13.pdf."},{"key":"389_CR39","unstructured":"Alderks CE. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update). The CBHSQ report: August 22, 2017. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017."},{"issue":"1","key":"389_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","volume":"38","author":"R Mojtabai","year":"2019","unstructured":"Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Medication treatment for opioid use disorders in substance use treatment facilities. Health Aff. 2019;38(1):14\u201323.","journal-title":"Health Aff."},{"issue":"8","key":"389_CR41","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","volume":"105","author":"CM Jones","year":"2015","unstructured":"Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55\u201363. https:\/\/doi.org\/10.2105\/AJPH.2015.302664.","journal-title":"Am J Public Health."},{"key":"389_CR42","unstructured":"Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing addiction in America: the surgeon general's report on alcohol, drugs, and health [Internet]. Washington, DC: US Department of Health and Human Services. Nov. Chapter 6, health care systems and substance use disorders; 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK424848\/."},{"key":"389_CR43","volume-title":"The TEDS report: predictors of substance abuse treatment completion or transfer to further treatment, by service type","author":"Substance Abuse and Mental Health Services Administration","year":"2009","unstructured":"Substance Abuse and Mental Health Services Administration. The TEDS report: predictors of substance abuse treatment completion or transfer to further treatment, by service type. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2009."},{"key":"389_CR44","volume-title":"National survey of substance abuse treatment services (N-SSATS): 2019. Data on substance abuse treatment facilities","author":"Substance Abuse and Mental Health Services Administration","year":"2020","unstructured":"Substance Abuse and Mental Health Services Administration. National survey of substance abuse treatment services (N-SSATS): 2019. Data on substance abuse treatment facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2020."},{"key":"389_CR45","unstructured":"Substance Abuse and Mental Health Services Administation. Behavioral health treatment services locator; 2021. https:\/\/findtreatment.samhsa.gov\/."},{"issue":"12","key":"389_CR46","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2105\/AJPH.2005.077628","volume":"96","author":"AM Kilbourne","year":"2006","unstructured":"Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113\u201321.","journal-title":"Am J Public Health."},{"issue":"1","key":"389_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.prcp.20190051","volume":"3","author":"C Barbosa-Leiker","year":"2020","unstructured":"Barbosa-Leiker C, Campbell ANC, McHugh RK, Guille C, Greenfield SF. Opioid use disorder in women and the implications for treatment. Psychiatr Res Clin Pract. 2020;3(1):3\u201311. https:\/\/doi.org\/10.1176\/appi.prcp.20190051.","journal-title":"Psychiatr Res Clin Pract."},{"issue":"5","key":"389_CR48","doi-asserted-by":"publisher","first-page":"e205734","DOI":"10.1001\/jamanetworkopen.2020.5734","volume":"3","author":"DM Schiff","year":"2020","unstructured":"Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3(5):e205734.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"389_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1940-0640-7-10","volume":"7","author":"PD Friedmann","year":"2012","unstructured":"Friedmann PD, Schwartz RP. Just call it \u201ctreatment\u201d. Addict Sci Clin Pract. 2012;7(1):10.","journal-title":"Addict Sci Clin Pract."},{"key":"389_CR50","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/add.14991","volume":"115","author":"N Krawczyk","year":"2020","unstructured":"Krawczyk N, Mojtabai R, Stuart E, Fingerhood M, Agus D, Lyons BC, et al. Opioid agonist treatment and fatal overdose risk in a statewide population receiving opioid use disorder services. Addiction. 2020;115:1683\u201394. https:\/\/doi.org\/10.1111\/add.14991.","journal-title":"Addiction."},{"key":"389_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jsat.2015.08.002","volume":"60","author":"GE Guerrero","year":"2015","unstructured":"Guerrero GE, Andrews C, Harris LM, Padwa H, Kong Y, Fenwick K. Improving coordination of addiction health services organizations with mental health and public health services. J Subst Abus Treat. 2015;60:45\u201353.","journal-title":"J Subst Abus Treat."},{"key":"389_CR52","doi-asserted-by":"publisher","unstructured":"Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, et al. Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA Psychiat. 2021; https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0247.","DOI":"10.1001\/jamapsychiatry.2021.0247"},{"key":"389_CR53","volume-title":"Admissions to and discharges from publicly-funded substance use treatment","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2018","year":"2019","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2018. Admissions to and discharges from publicly-funded substance use treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019."},{"issue":"4","key":"389_CR54","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/1475-6773.12031","volume":"48","author":"GE Guerrero","year":"2013","unstructured":"Guerrero GE, Marsh JC, Duan L, Oh C, Perron B, Lee B. Disparities in completion of substance abuse treatment between and within racial and ethnic groups. Health Serv Res. 2013;48(4):1450\u201367. https:\/\/doi.org\/10.1111\/1475-6773.12031.","journal-title":"Health Serv Res."},{"key":"389_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1747-597X-7-34","volume":"7","author":"EG Guerrero","year":"2012","unstructured":"Guerrero EG, Campos M, Urada D, Yang JC. Do cultural and linguistic competence matter in Latinos\u2019 completion of mandated substance abuse treatment? Subst Ab Treatment Prev Policy. 2012;7:34. https:\/\/doi.org\/10.1186\/1747-597X-7-34.","journal-title":"Subst Ab Treatment Prev Policy."},{"key":"389_CR56","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.addbeh.2012.05.006","volume":"37","author":"EG Guerrero","year":"2012","unstructured":"Guerrero EG, Cepeda A, Duan L, Kim T. Disparities in completion of substance abuse treatment among Latino subgroups in Los Angeles County, CA. Addict Behav. 2012;37:1162\u20136. https:\/\/doi.org\/10.1016\/j.addbeh.2012.05.006.","journal-title":"Addict Behav."},{"issue":"1","key":"389_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/ebmh.13.1.26","volume":"13","author":"S George","year":"2010","unstructured":"George S. Review: methadone increases retention and reduces heroin use compared with non-pharmacological maintenance. Evid Based Ment Health. 2010;13(1):26. https:\/\/doi.org\/10.1136\/ebmh.13.1.26.","journal-title":"Evid Based Ment Health."},{"key":"389_CR58","volume-title":"Admissions to and discharges from publicly-funded substance use treatment","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2017","year":"2019","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2017. Admissions to and discharges from publicly-funded substance use treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019."},{"key":"389_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1086\/341182","volume":"76","author":"EM Durkin","year":"2002","unstructured":"Durkin EM. An organizational analysis of psychosocial and medical services in drug abuse treatment programs. Soc Serv Rev. 2002;76:406\u201329.","journal-title":"Soc Serv Rev."},{"key":"389_CR60","unstructured":"NIDA. Effective treatments for opioid addiction; 2016 Nov 1. https:\/\/www.drugabuse.gov\/publications\/effective-treatments-opioid-addiction. Accessed 9 May 2021."}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-021-00389-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:15:33Z","timestamp":1624436133000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00389-4","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"9 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Institutional Review Board of the University of Chicago (IRB18-1657). The co-principal investigator, also the corresponding author, has obtained consent to publish from the participants in this study (treatment clients and program staff members).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}